La cadena de opciones muestra datos clave de las opciones de acciones de Quantum BioPharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Quantum BioPharma..

Quantum BioPharma (NASDAQ:QNTM) Bolsa, Cadena de Opciones

Quantum BioPharma

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEMD

APCX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

DSGN

ELAB

KULR

LITM

MESO

NVNI

PTPI

QNTM

SGMO

SLXN

VRAX

Acciones de Sangamo Therapeutics suben un 19,5% tras un nuevo acuerdo. Descubre los mayores ganadores y perdedores de hoy.

Acciones de Sangamo Therapeutics (SGMO) suben alrededor de un 20%; 20 acciones que se mueven en el premercado

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

Quantum BioPharma Ltd

The cryptocurrency market cracked further Thursday as risk sentiment remained low following the Federal Reserve&#8217;s hawkish statements.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 7:45 p.m. ET)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>-3.30%</td>
<td>$97,251.29</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>-6.08%</td>
<td>$3,425.34</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>-12.28%</td>
<td>$0.3159</td>
</tr>
</tbody>
</table>
</figure>
What Happened: Bitcoin rallied to $102,000 in the early hours but gave up gains as the day progressed, dipping below $96,000 for the first time in over a month.
Similarly, Ethereum lifted above $3,700 only to crash below $3,400 by late afternoon. The world's second-largest cryptocurrency was down over 11% over the week.
Over $1 billion was liquidated from the cryptocurrency market in the last 24 hours, with long liquidations accounting for $860 million.&nbsp;
Bitcoin's Open Interest plunged 4.24% in the last 24 hours, alongside a drop in spot price. That said, the percentage of Binance traders taking long positions for the cryptocurrency rose sharply to 61%, against 38% betting against the asset, according to the Long/Short Ratio.
The "Greed" sentiment weakened in the market, according to the Cryptocurrency Fear &amp; Greed Index.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 7:45 p.m. ET)</td>
</tr>
<tr>
<td>Movement (MOVE)</td>
<td>+21.14%</td>
<td>$0.7626</td>
</tr>
<tr>
<td>Bitget Token (BGB)</td>
<td>+6.55%</td>
<td>$4.46</td>
</tr>
<tr>
<td>Mantle (MNT)</td>
<td>+6.50%</td>
<td>$1.17</td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency market capitalization stood at $3.33 trillion, following a contraction of 4.91% in the last 24 hours.
The Dow Jones Industrial Average snapped out of its 10-day losing streak Thursday but only just, gaining 0.04%, to close at 42,342.24. The S&amp;P 500 slipped 0.09% to end at 5,867.08, while the tech-heavy Nasdaq Composite dropped 0.10% to 19,372.77.
These moves come a day after the stock market got hammered <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42563299/feds-powell-shocks-markets-its-a-new-phase-were-significantly-closer-to-neutral">after the Federal Reserve signaled a hawkish outlook</a>, with fewer rate reductions in 2025 than expected.
The benchmark 10-year Treasury yields increased to 4.55%, the highest since May 30.
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: Widely followed cryptocurrency analyst and trader Ali Martinez commented on Bitcoin's latest moves, stating that if the apex cryptocurrency loses $96,000 as support, it could dip further to $90,000 and $85,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Keeping it simple, just based on the Fib, if <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> loses $96,000, the next point of focus becomes $90,000 and $85,000. <a href="https://t.co/yJ1Hq2PNe2">pic.twitter.com/yJ1Hq2PNe2</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1869851163061039116?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Rekt Capital, another influential analyst, stated that if Bitcoin goes below the weekly support level of around $97,800, the 5-week uptrend will be reversed and the coin will enter a corrective phase.
"If this blue weekly support region fails and so does the 5-week uptrend (orange)&#8230; then BTC will probably transition into a correction."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> The Bearish Engulfing Candle persists And the Weekly level at $101.2k is struggling to hold as support If this blue Weekly support region fails and so does the 5-week uptrend (orange)&#8230; Then BTC will probably transition into a correction<a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://twitter.com/hashtag/Crypto?src=hash&amp;ref_src=twsrc%5Etfw">#Crypto</a> <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://t.co/KnIptVe958">https://t.co/KnIptVe958</a> <a href="https://t.co/7oYdQ5v2r6">pic.twitter.com/7oYdQ5v2r6</a>
&mdash; Rekt Capital (@rektcapital) <a href="https://twitter.com/rektcapital/status/1869808384574402864?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42601193/senator-lummis-introduces-strategic-bitcoin-reserve-proposal">Senator Lummis Introduces Strategic Bitcoin Reserve Proposal</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

Bitcoin, Ethereum, Dogecoin Retreat Further As Crypto Liquidations Top $1 Billion: Analyst Lays Out Scenario For BTC Losing $96K Support

U.S. stock markets could benefit from fewer interest rate cuts in 2025 despite recent volatility, according to Fundstrat&#8216;s head of research Tom Lee, who sees the Federal Reserve&#8217;s hawkish stance as <a href="https://www.benzinga.com/24/12/42599089/us-stocks-edge-up-micron-suffers-worst-day-since-march-2020-bond-yields-surge-whats-driving-markets-thursday">potentially beneficial for investors</a>.
What Happened: &#8220;The fewer cuts [the Fed does] in 2025, it actually is better for this bull market because it provides a lot of future ammunition to protect the economy,&#8221; Lee said on Thursday, according to Fundstrat.
The comments followed a tumultuous period in markets, with the Dow Jones Industrial Average as tracked by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) struggling through its longest losing streak since 1974 and the S&amp;P 500 tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), suffering its steepest one-day <a href="https://www.benzinga.com/markets/equities/24/12/42567950/jim-cramer-warns-of-incredible-panic-as-jerome-powells-cautious-rate-cuts-send-us-stocks-into-freefall">decline since September 2022</a>.
The selloff was triggered after the Federal Reserve cut rates by 25 basis points to 4.25%-4.5% but signaled just two rate cuts for 2025, down from <a href="https://www.benzinga.com/24/12/42599089/us-stocks-edge-up-micron-suffers-worst-day-since-march-2020-bond-yields-surge-whats-driving-markets-thursday">four projected in September</a>.
The central bank&#8217;s shift rattled investors who had been counting on more aggressive rate cuts. However, recent economic data continues to show resilience, with third-quarter GDP growth revised upward to 3.1% and weekly jobless claims falling to 220,000, below expectations of 230,000.
See Also: <a href="https://www.benzinga.com/news/earnings/24/12/42606549/blackberry-beats-q3-earnings-estimates-but-soft-guidance-keeps-shares-in-check">BlackBerry Beats Q3 Earnings Estimates, But Soft Guidance Keeps Shares In Check</a>
Why It Matters: &#8220;I know yesterday&#8217;s pullback was really painful, but to us, the fundamentals supporting stocks are intact,&#8221; Lee said. He suggested that recent market declines might be driven by panicked investors selling out of momentum trades as the year ends.
The hawkish Fed outlook has particularly impacted the bond market, with 30-year Treasury yields climbing to 4.75%. Despite these headwinds, Lee maintains a bullish stance, recommending investors &#8220;buy the dip.&#8221;
Wharton Professor Emeritus Jeremy Siegel offered a similar perspective, calling the market&#8217;s reaction a &#8220;healthy&#8221; reality check after what he described as &#8220;overly optimistic&#8221; <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42570219/whartons-jeremy-siegel-calls-stock-sell-off-a-healthy-reality-check-market-was-overly-optimistic">expectations for rate cuts</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42605034/fedex-stock-rallies-on-better-than-expected-q2-eps-freight-spin-off-announcement">FedEx Stock Rallies On Better-Than-Expected Q2 EPS, Freight Spin-Off Announcement</a></li>
</ul>
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

SPDR Dow Jones Industrial Average ETF Trust

Tom Lee Explains Why 'Fewer Cuts In 2025' Could Boost The Market, Urges Investors To 'Buy The Dip' Amid Recent Volatility

Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) plans to introduce a new AI video editing feature in 2025.
What Happened: On Thursday, Head of Instagram, Adam Mosseri, shared a teaser video of the AI tool that lets users tweak nearly every video detail with just a text prompt.
Powered by Meta&#8217;s Movie Gen AI, the tool simplifies video transformations for creators without advanced editing skills.
See Also: <a href="https://www.benzinga.com/tech/24/12/42570376/jeff-bezos-backed-perplexity-raises-500-million-tripling-its-valuation-to-9-billion-as-competition-with-google-and-openai-heats-up?itm_source=parsely-api">Jeff Bezos-Backed Perplexity Raises $500 Million, Tripling Its Valuation To $9 Billion As Competition With Google And OpenAI Heats Up</a>
The teaser shows AI altering Mosseri&#8217;s appearance and background, as well as turning him into a felt puppet.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/19202935/Screenshot-2024-12-20-at-6.51.48%E2%80%AFAM-1024x868.png" alt="" class="wp-image-700744" /><figcaption class="wp-element-caption">Source: Instagram</figcaption></figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Subtle edits, like adding objects or accessories like a gold chain, blend seamlessly without distortion. However, OpenAI's Sora video model initially impressed with polished previews, but its public release fell short of expectations.
It remains to be seen whether Instagram's AI video tools will deliver on their promise once they debut.
Meta first introduced its Movie Gen AI <a href="https://www.benzinga.com/top-stories/24/10/41188250/metas-movie-gen-brings-ai-powered-video-audio-creation-to-all">video generator in October</a>. While the exact release date remains unannounced, Instagram will be the first platform to integrate this innovative text-to-video model.
In September 2024, Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) also unveiled its <a href="https://www.benzinga.com/markets/equities/24/09/40819405/adobe-shakes-up-video-editing-with-ai-powered-creation-tools-whats-on-the-cards">generative AI video capabilities</a> with the Adobe Firefly Video Model.
Image via Unsplash
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/24/12/42509206/soundhound-ai-soars-over-700-short-squeeze-potential-has-traders-talking?itm_source=parsely-api">SoundHound AI Soars 700%: Short Squeeze Potential Has Traders Talking</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Tech

Media

ADBE

Instagram Boss Shows How You Can Turn Yourself Into A Puppet — And That's Just The Beginning

On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably selling off Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) stock.
The Tesla Trade
The ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) reduced its holdings in Tesla Inc. by selling 14,016 shares. This move comes amidst a month where Tesla&#8217;s stock has been on a remarkable upswing, reaching new highs. The Elon Musk-led company&#8217;s stock has risen over 26% in December.
The shares were sold at a closing price of $436.17, totaling approximately $6.1 million in value. This decision follows a <a href="https://www.benzinga.com/24/12/42476448/cathie-woods-ark-invest-dumps-another-15-3-million-tesla-shares-pivots-to-this-flying-taxi-startup">previous sale</a> of Tesla shares by Ark Invest on Wednesday when the firm sold another $9.06 million worth of stock. These sales took place not long after Musk expressed optimism that the stock could touch the $690 mark.
The Palantir Trade
On the same day, Ark Invest sold Palantir stock. The firm sold 33,402 shares of the Alex Karp-led company through ARKK. The transaction was valued at $2.5 million with shares closing at $74.21 on Thursday.
This decision comes on the heels of Palantir&#8217;s recent announcement of a $400.7 million <a href="https://www.benzinga.com/24/12/42572384/palantir-strengthens-army-partnership-adds-ai-and-data-enhancements-in-400-million-deal">contract extension</a> with the U.S. Army, with a total potential ceiling of $618.9 million. The agreement aims to operationalize data across the entire Department of the Army, enabling broader integration of data and AI capabilities. Despite the company&#8217;s stock climbing 350% year-to-date and nearly 18% in December, company insiders have been <a href="https://www.benzinga.com/24/12/42538479/palantir-stock-rockets-350-ytd-but-insiders-cash-out-should-you-follow-suit">selling off shares</a>.
Other Key Trades:
<ul>
<li>ARKG and ARKK bought shares of Tempus AI Inc (TEM). ARKG sold shares of Ionis Pharmaceuticals Inc. (IONS).</li>
<li>ARKG also bought shares of Personalis Inc (PSNL).</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42545829/mark-cuban-expresses-sympathy-for-hawk-tuah-girl-amid-meme-coin-controversy-wasnt-something-she-fully-understood?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban Expresses Sympathy For &#8216;Hawk Tuah&#8217; Girl Amid Meme Coin Controversy: &#8216;Wasn&#8217;t Something She Fully Understood&#8217;</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

ETFs

ARKK

PLTR

TSLA

Cathie Wood's Thursday Moves: Dumps Buzzing Stocks Tesla And Palantir

On Thursday, the House turned down a contingency plan proposed by House Speaker Mike Johnson (R-La.) aimed at averting a government shutdown and suspending the debt limit.
What Happened: Johnson&#8217;s measure, introduced only hours before the vote, failed to secure the necessary two-thirds majority for approval, receiving a 174-235-1 vote, <a href="https://thehill.com/homenews/house/5049768-government-funding-debt-ceiling-bill-fails/">reported</a> The Hill. The bill encountered opposition from Democrats, led by Minority Leader Hakeem Jeffries (N.Y.), along with a few conservative Republicans, mainly due to its inclusion of a two-year debt limit suspension, a provision requested by President-elect Donald Trump.
The future course of action for Johnson remains uncertain. With&nbsp;the Republican opposition, the bill&nbsp;is unlikely to pass if Johnson tries to push it through a regular rule process that only requires a simple majority.
If no legislation is approved by Congress&nbsp;by 11:59 p.m. on Friday,&nbsp;the government will face a shutdown. This failed vote is a setback for Johnson, who is striving to prevent a shutdown by the impending deadline and retain his leadership position in the coming year.

The proposed bill would have maintained the government funding at existing levels through March 14, suspended the debt limit for two years, and allocated approximately $100 billion in disaster relief and about $10 billion for farmer economic assistance.
Despite President-elect Trump&#8217;s endorsement of the package, a few Republicans promptly rejected the legislation. Democrats also overwhelmingly opposed the bill, with lawmakers reportedly chanting &#8220;hell no&#8221; during a closed-door House Democratic Caucus meeting after the bill&#8217;s introduction.
See Also: <a href="https://www.benzinga.com/24/12/42545204/marjorie-taylor-greene-pushes-to-sell-off-usps-amid-doge-momentum-we-need-to-privatize-ive-been-saying-it-for-years?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Pushes To Sell Off USPS Amid DOGE Momentum: &#8216;We Need To Privatize&#8230;I&#8217;ve Been Saying It For Years&#8217;</a>
Why It Matters: Earlier, U.S. Congressional leaders had <a href="https://www.benzinga.com/24/12/42544562/congressional-leaders-reach-bipartisan-deal-to-avert-government-shutdown">reached a bipartisan agreement</a> to extend government funding and avert a shutdown. However, this agreement was rejected by House Republicans under pressure from President-elect Trump, Vivek Ramaswamy and Elon Musk, leading to the current situation. Ramaswamy and Musk are the leaders of the Department of Government Efficiency, a body whose task it is to cut wasteful government spending. 
Trump&#8217;s unexpected dismissal of the bipartisan proposal has escalated the fears of a U.S. government shutdown ahead of Christmas. However, research firm Edward Jones suggests that markets tend to remain positive half the times during past government shutdowns since 1976, despite the short-term volatility introduced by such political events.
House Mike Johnson. Photo via Shutterstock.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

House Rejects Trump-Endorsed Backup Plan To Prevent Government Shutdown And Suspend Debt Limit: Lawmakers Chant 'Hell No'

The House Artificial Intelligence Task Force released a report on Tuesday with recommendations on how Congress can boost the development of AI while also protecting against potential risks <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42561047/amazon-meta-alphabet-spotify-lead-jpmorgans-2025-tech-picks-for-ai-potential">of the technology. </a>
The Details: The bipartisan House AI task force, chaired by Rep. Jay Obernolte (R-Calif.), released the 253-page<a href="https://www.speaker.gov/wp-content/uploads/2024/12/AI-Task-Force-Report-FINAL.pdf"> document</a> as the culmination of the group's work which began in February.
Obernolte said the report is just the "beginning of the conversation" around AI policy. 
"It will only be effective if future Congresses implement some of the recommendations that we have created," he added.&nbsp;
Read More: <a href="https://www.benzinga.com/general/social-media/24/12/42598651/mystery-drone-sightings-all-over-the-country-trump-says-what-to-know-about-investigations-lawmakers-reactions">&#8216;Mystery Drone&#8217; Sightings Spark Investigations, Politicians Respond: &#8216;Shoot Them Down,&#8217; Trump Says</a>
The representative said the task force met to consider bills that it could endorse and introduce for passage this Congress, but the group agreed not to do so in order to remain bipartisan. 
"Disagreements started to emerge about the language in each individual bill and we realized that if we wanted to maintain this coalition that was broadly bipartisan … it probably was counterproductive to actually be talking about legislative language," Obernolte said.
The report contains 66 key findings and 89 recommendations across 14 areas and will serve as the foundation for future legislative action on AI. The effects of future AI legislation will ripple across industries, government agencies and individuals.&nbsp;
Why It Matters: The task force wrote in its report that the government should lead by example and foster trust in AI by using the technology to improve efficiency and services while adopting responsible policies surrounding its use.&nbsp;
Companies that are sufficiently large and capable of handling the government's needs, like Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) could benefit from contracts to supply agencies and departments with AI services. 
The House task force also highlighted the importance of promoting AI innovation which may include further legislation like the CHIPS and Science Act, which was designed to promote U.S. semiconductor manufacturing. Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) received more than $7 billion in direct funding and Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) received $6.6 billion in funding from the program.
Another principle the task force emphasized was its duty to protect against AI-related risks and harms. Companies developing large AI models, such as OpenAI and Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) may need to report on training and safety processes if the government determines they could pose security or public health risks. 
The task force also suggested that future Congresses take an "incremental approach" to AI regulation as the technology is rapidly evolving and legislation will need to adapt and evolve as well.&nbsp;
"What we're embracing here is incrementalism. We don't think it's important that everyone agrees on every single aspect of AI immediately," Obernolte said.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42564443/santa-came-early-with-rate-cut-but-federal-reserve-brings-coal-next-year-experts-weigh-in-on-rate-cut-feds-2025-projections">&#8216;Santa Came Early&#8217; But Fed Brings &#8216;Coal Next Year&#8217;: Experts Weigh In On Interest Rate Cut, 2025 Projections</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

GOOG

GOOGL

INTC

Here's What The Latest Congressional AI Report Could Mean For Big Tech

Residents in one state could lease a new vehicle with a $0 down and $0 a month offer before taxes, in a move that could increase<a href="https://www.benzinga.com/electric-vehicles"> electric vehicle adoption.</a>
 What Happened: With concerns that electric vehicle regulatory credits <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">could disappear</a> under President-elect Donald Trump, residents in the state of Colorado may want to hear more about the latest offer.
The Larry H. Miller Chrysler Dodge Ram FIAT Denver dealership, which sells and leases Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) vehicles has a <a href="https://www.lhmchryslerdodgeramfiatdenver.com/fiat-offer.htm">new </a>$0 down, $0 a month offer for the Fiat 500e.
The 27-month lease, with a 10,000 mile per year allowance, has the new offer available to select customers.
Customers will still have to pay taxes on the offer, which total around $1,298 according to an Electrek <a href="https://electrek.co/2024/12/18/crazy-fiat-500e-prices-are-back-you-can-lease-one-for-0-mo-yes-zero-in-co/">report</a>, along with a $395 disposition fee, totaling around $1,693. This calculates out to around $63 per month for a new electric vehicle lease.
Read Also:<a href="https://www.benzinga.com/news/management/24/12/42258470/jeep-marker-stellantis-ceo-carlos-tavares-resigns-amid-falling-us-sales-and-trade-pressures-board-cites-different-views"> Jeep Maker Stellantis&#8217; CEO Carlos Tavares Resigns Amid Falling US Sales And Trade Pressures: Board Cites &#8216;Different Views&#8217; &nbsp;</a>
Why It's Important: The new offer highlights how Colorado is one of the most friendly states when it comes to electric vehicles, which includes $7,500 in state tax credits on select EVs on top of $7,500 in federal tax credits. 
<a href="https://www.benzinga.com/news/23/08/33589652/tesla-vehicle-for-under-15-000-not-yet-but-this-state-has-incentives-to-get-the-price-under-20-000">Benzinga previously reported </a>that combining federal and state credits on a Tesla Model 3 RWD in August 2023 could get the starting price from $40,240 to under $20,000.
"Very compelling," Tesla CEO Elon Musk said at the time. &nbsp;
<a href="https://www.benzinga.com/news/24/07/39677353/electric-vehicle-lease-for-19-a-month-dealership-in-this-state-has-new-offer-to-lure-customers">Benzinga also shared </a>that a Colorado Nissan dealer was offering a $0 down, $ 19 a month offer ($79 per month with fees) on a 2025 Nissan Leaf S earlier this year.
Colorado Gov. Jared Polis made a push to see more electric vehicles sold in the state, with a goal of one million plug-in vehicles on the road by 2030.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42273230/stellantis-market-value-halves-in-2024-why-ceo-tavares-exit-could-take-things-from-bad-to-worse">Stellantis Market Value Halves In 2024: Why CEO Tavares&#8217; Exit Could Take Things From Bad To Worse</a></li>
</ul>
Photo: Fiat 500e, Courtesy Stellantis

STLA

EV Lease Nearly Free With $0 Down, $0 Month Offer In This State

Cansortium Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TIUM#CSE">TIUM</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTCQB">CNTMF</a>) also known as "FLUENT" and RIV Capital Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#CSE">RIV</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) announced on Thursday the completion of a previously announced arrangement with RIV Capital whereby FLUENT acquired all of the issued and outstanding Class A common shares of RIV Capital in exchange for FLUENT shares.
Under the terms of the agreement, RIV Capital shareholders received 1.245 of a common share of FLUENT in exchange for each RIV Capital share held. As a result, shareholders of FLUENT hold approximately 51.25% of the combined business of FLUENT and RIV Capital shareholders and The Hawthorne Collective together, hold approximately 48.75% of the combined company, each on a fully diluted basis.
Read Also: <a href="https://www.benzinga.com/24/11/42244572/cannabis-focused-riv-capital-reports-186-yoy-surge-in-q3-revenue-ahead-of-merger-that-will-cover-25-of-us-population">Cannabis-Focused RIV Capital Reports 186% YoY Surge In Q3 Revenue Ahead Of Major Merger That Will Cover 25% Of US Population</a>
The combined company will continue to operate under the FLUENT name. FLUENT shares will continue to trade on the Canadian Securities Exchange under the symbol "TIUM.U" and on the OTCQB Venture Market under the symbol "CNTMF."
Robert Beasley has been named CEO of the combined company. RIV shares were delisted from the CSE at market close on Dec. 19, 2024. The company will cause RIV Capital to apply to the relevant Canadian securities regulatory authorities to cease to be a reporting issuer under applicable Canadian securities laws.
<h1 class="wp-block-heading">Management Commentary</h1>
"I am thrilled to complete this transaction, and I would like to thank our combined teams for all of their hard work over the past few months and our shareholders for their strong support," said Beasley. "Together, we have created one of the most well-positioned cannabis operators in the industry, with a strategic footprint in four key growth markets and a strong balance sheet which will allow us to act on accretive growth opportunities."
Beasley added, "With New York legal retail sales on pace to exceed $1 billion by year-end, our recent successful launch of MOODS in New York underscores the immense potential of the Combined Company, as we have introduced FLUENT's brands to scale the wholesale operations and gain additional shelf space in dispensaries across the state."
David Vautrin, former chief revenue officer and interim CEO of RIV Capital and, upon closing, now chief commercial officer of FLUENT called the deal transformational.
"This is a transformational deal for RIV Capital and represents the culmination of substantial work for both FLUENT and RIV Capital," Vautrin said. "As evidenced by past performance, we believe FLUENT is one of the most fundamentally sound and now one of the most well-positioned multi-state operators in the US.."
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/12/42597912/pesticides-in-pot-the-overlooked-dangers-of-californias-legal-weed">Pesticides In Pot: Overlooked Dangers Of California&#8217;s Legal Weed</a></li>
</ul>
Courtesy photo

Cannabis

Retail Sales

CNPOF

CNTMF

CSE:RIV

CSE:TIUM

Cansortium Completes RIV Capital Acquisition, Adding New York Retail, Wholesale, Cannabis Cultivation Operations

IONS

Trading Halt: Halt status updated at 6:55:00 PM ET: Quotation Resumption: News and Resumption Times

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) hit new yearly highs recently as the overall cryptocurrency sector has traded higher since Donald Trump won the<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41778425/bitcoins-all-time-high-a-groundbreaking-milestone-and-strong-post-election-rally-coming-ex"> 2024 presidential election.</a>
A new Benzinga poll asks readers if Dogecoin will trade closer to levels seen before the election or all-time highs set back in 2021.
What Happened: Dogecoin traded between 15 cents and 18 cents on Nov. 5, the day of the U.S. presidential election. Like many cryptocurrencies, Dogecoin <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41890024/much-wow-dogecoin-is-now-larger-than-ford-adidas-lululemon-roblox-15-companies-worth-less-than-meme-crypto">gained in the days </a>and weeks after Trump's victory.
Helped by Trump's victory, optimism for a pro-crypto White House administration and the appointment of Dogecoin supporter Elon Musk as head of the Department of Government Efficiency, or D.O.G.E. for short, the meme cryptocurrency hit new <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42274989/dogecoins-insane-165-growth-in-november-is-just-the-first-candle-traders-speculate">yearly highs in November </a>and December.
Benzinga recently asked if the recent momentum in Dogecoin and future optimism would see Dogecoin more likely to trade closer to an all-time high of $0.7376 set in May 2021 or back to the $0.25 level last seen on Nov. 10 shortly after the election.
"Which level is Dogecoin more likely to reach next: 69 cents or 25 cents?" Benzinga asked.
The results were:
<ul>
<li>69 Cents: 78%</li>
<li>25 Cents: 22%</li>
</ul>
The poll found over three-fourths of readers predict Dogecoin is more likely to hit 69 cents before hitting 25 cents again.
This would suggest that Dogecoin has more gains ahead and would set new 52-week highs and get close to all-time highs.
The last time Dogecoin hit 69 cents was on May 9, 2021, the day after the all-time high was set. Dogecoin traded at 69 cents or higher on four occasions in May 2021.
Dogecoin has traded between $0.07497 and $0.4835 over the [ast year, with the high set in early December.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41908812/if-you-invested-100-in-dogecoin-when-the-meme-coin-launched-heres-how-much-youd-have-today">If You Invested $100 In Dogecoin When The Meme Coin Launched, Here&#8217;s How Much You&#8217;d Have Today</a>
Why It's Important: Recent polls have shown continued optimism for Dogecoin, which is one of the 10 most valuable cryptocurrencies by market capitalization.
A recent <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41945659/dogecoin-to-69-cents-or-1-benzinga-readers-predict-how-high-it-could-fly-by-end-of-2024">November Benzinga poll</a> asked what Dogecoin's highest price by the end of 2024 would be.  
The results were:
<ul>
<li>42 cents: 10%</li>
<li>69 cents: 24%</li>
<li>New All-Time Highs (73.77 cents): 18%</li>
<li>$1.00: 17%</li>
<li>None of the above: 31%</li>
</ul>
The highest percentage of readers thought that none of the price targets would be reached by Dogecoin. The next highest result was 69 cents, which would take Dogecoin close to all-time highs and a memeable number before year-end.
Only 18% of readers think that Dogecoin will reach all-time highs before the end of the year, and a lower percentage (17%) believe Dogecoin will hit a price of $1.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42378513/can-bitcoin-ethereum-dogecoin-shiba-inu-or-solana-beat-xrp-in-2025-poll-says-yes-one-coin-stands-out">A December poll </a>asked if any of the top cryptocurrencies could outperform fast-moving XRP in 2025. The possible answers were Bitcoin, Solana, Dogecoin, Ethereum, Shiba Inu, Hedera or none of the above, meaning XRP would be the top gainer in 2025.
Dogecoin ranked fourth in the poll at 13%, with Bitcoin won the poll at 28%, followed by None of the Above at 24% and Solana at 15%.
DOGE Price Action: Dogecoin trades at $0.3205 at the time of writing, down 11% over the last 24 hours and down 17% over the past month. Despite the recent drop in price, the price of Dogecoin is up over 240% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42440369/bitcoins-next-move-105000-or-85000-poll-finds-over-60-say">Bitcoin&#8217;s Next Move: $105,000 Or $85,000? Poll Finds Over 60% Say…</a></li>
</ul>
The study was conducted by Benzinga from Dec. 11 through Dec. 12, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 123 adults.
Photo: Shutterstock

Exclusives

Dogecoin Down 17% In One Month, Will Meme Crypto Reach 25 Cents Or 69 Cents First? 78% Of Readers Say…

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 11.19% on an annualized basis producing an average annual return of 22.11%. Currently, Meta Platforms has a market capitalization of $1.51 trillion. 
Buying $1000 In META: If an investor had bought $1000 of META stock 10 years ago, it would be worth $7,388.29 today based on a price of $597.04 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734651910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Meta Platforms 10 Years Ago Would Be Worth This Much Today

The debate over how to tackle America's obesity epidemic that affects 40% of adults and nearly<a href="https://www.benzinga.com/general/biotech/24/02/37157967/whats-gaining-popularity-among-us-teens-battling-obesity-novo-nordisks-weight-loss-drug-wegovy" target="_blank" rel="noreferrer noopener">&nbsp;20% of children</a>, has sparked contrasting views from two influential voices in President-elect Donald J. Trump's orbit. The side that wins could have a lasting impact on public health in the U.S.
Robert F. Kennedy Jr., <a href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower">Trump's pick</a> for secretary of Health and Human Services (HHS), says lifestyle changes need to be a big part of the solution.
Elon Musk, billionaire tech entrepreneur and seemingly one of Trump's closest advisers, is calling for easier access to weight loss drugs such as <a href="https://www.benzinga.com/topic/ozempic">Ozempic</a> and <a href="https://www.benzinga.com/topic/wegovy">Wegovy</a>, produced by Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>). Musk, who has used Wegovy, said on X that &#8220;nothing else is even close&#8221; when considering how to address obesity, <a href="https://www.nytimes.com/2024/12/18/health/ozempic-food-rfk-elon-musk.html">noted</a> the New York Times. "Nothing would do more to improve the health, lifespan, and quality of life for Americans than making GLP inhibitors super low cost to the public."
Kennedy, meanwhile, says if approved to lead the HHS, he'll roll out an anti-obesity plan that will focus on healthier nutrition and encouraging Americans to make time for daily exercise. Kennedy told Fox News' Greg Gutfeld before the election that the makers of obesity drugs are &#8220;counting on selling it to Americans because we're so stupid and so addicted to drugs.&#8221;
<h1 class="wp-block-heading">Suicide and Ozempic?</h1>
Kennedy <a href="https://www.youtube.com/watch?v=qX9nQ40mSMY">said in the same Fox News appearance</a> that the European Union "is right now investigating Ozempic for suicidal ideation," although the EU regulator concluded in April that available evidence does not suggest Ozempic and other weight-loss drugs cause suicidal thoughts or actions.
Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota says such confident although false or misleading assertions are Kennedy's trademark. And they can be dangerous, Osterholm warned, when applied to public health bedrocks like vaccines.
"He acts like he knows what he's talking about when he doesn't, and he says things with a definition that makes people convinced he has the data to support his statement," Osterholm <a href="https://www.cnn.com/2024/11/17/health/rfk-jr-ozempic/index.html">told</a> CNN two weeks after the November election. "Trying to follow him and understand what he's talking about is often like trying to nail Jell-O to the wall."
Kennedy and Musk's competing perspectives underscore the difficult path toward dealing with the U.S.'s <a href="https://www.benzinga.com/news/24/03/37413349/ozempic-wegovy-other-weight-loss-drugs-wont-solve-global-obesity-crisis-affecting-1b-people-who-warn" target="_blank" rel="noreferrer noopener">severe obesity epidemic</a>: lifestyle changes vs. pharmaceuticals.
<h1 class="wp-block-heading">Cannabis a Solution?</h1>
Some people may look to <a href="https://www.benzinga.com/cannabis">cannabis</a> for a natural solution. Recent studies have <a href="https://www.nature.com/articles/s41366-023-01399-x" target="_blank" rel="noreferrer noopener">suggested</a> &#8220;cannabis and subproducts could be considered adjuncts in obesity treatment by helping to reduce relevant anthropometric measurements.&#8221;
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42491683/rfk-jrs-lawyer-urges-fda-to-revoke-polio-vaccine-approval-endangering-millions-of-children">Kennedy&#8217;s Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children</a></li>
</ul>

Health Care

Elon Musk Vs. RFK Jr.: Obesity Crisis Debate Sparks Struggle For Trump's Influence

Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) has outperformed the market over the past 20 years by 1.81% on an annualized basis producing an average annual return of 10.01%. Currently, Nike has a market capitalization of $115.16 billion. 
Buying $1000 In NKE: If an investor had bought $1000 of NKE stock 20 years ago, it would be worth $6,789.21 today based on a price of $77.37 for NKE at the time of writing.
<h3>Nike's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734651013_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Nike 20 Years Ago Would Be Worth This Much Today

Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) has outperformed the market over the past 15 years by 14.86% on an annualized basis producing an average annual return of 26.48%. Currently, Chipotle Mexican Grill has a market capitalization of $84.14 billion. 
Buying $1000 In CMG: If an investor had bought $1000 of CMG stock 15 years ago, it would be worth $34,170.91 today based on a price of $61.75 for CMG at the time of writing.
<h3>Chipotle Mexican Grill's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734650109_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Chipotle Mexican Grill Stock In The Last 15 Years

Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) has outperformed the market over the past 15 years by 4.07% on an annualized basis producing an average annual return of 15.69%. Currently, Verisk Analytics has a market capitalization of $38.91 billion. 
Buying $100 In VRSK: If an investor had bought $100 of VRSK stock 15 years ago, it would be worth $894.74 today based on a price of $275.58 for VRSK at the time of writing.
<h3>Verisk Analytics's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734649208_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRSK

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Jones Lang LaSalle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JLL#NYSE">JLL</a>) has outperformed the market over the past 20 years by 1.69% on an annualized basis producing an average annual return of 9.89%. Currently, Jones Lang LaSalle has a market capitalization of $11.72 billion. 
Buying $1000 In JLL: If an investor had bought $1000 of JLL stock 20 years ago, it would be worth $6,666.58 today based on a price of $246.93 for JLL at the time of writing.
<h3>Jones Lang LaSalle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734648313_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth This Much Today

BlackBerry Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) reported third-quarter financial results after the market close on Thursday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/24/12/ac42605872/blackberry-reports-third-quarter-fiscal-year-2025-results">from the quarter</a>.
Q3 Earnings: BlackBerry reported third-quarter revenue of $162 million. The company reported third-quarter adjusted earnings of two cents per share, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> for a loss of one cent per share, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
IoT revenue was&nbsp;$62&nbsp;million, up 13% year-over-year.&nbsp;Cybersecurity revenue totaled $93&nbsp;million in the quarter, up 7% year-over-year. Licensing revenue&nbsp;came in at $7&nbsp;million.
Total company gross margin was 74% in the quarter. Operating cash flow improved by $34 million year-over-year to $3 million. BlackBerry ended the quarter with $266 million in&nbsp;cash, cash equivalents and&nbsp;short-&nbsp;and long-term investments.
&#8220;BlackBerry achieved a significant inflection in its results this past quarter. Driven by a combination of strong revenue performance for both our Cybersecurity and IoT divisions, and continued focus on costs and efficiency, the company delivered stronger than expected profitability and a return to positive cash flow ahead of schedule,&#8221; said John Giamatteo, CEO of BlackBerry. 
From Last Week: <a href="https://www.benzinga.com/24/12/42477300/russian-state-backed-hackers-target-ukrainian-military-devices-via-spacexs-starlink-microsoft-report-reveals">Russian State-Backed Hackers Target Ukrainian Military Devices Via SpaceX&#8217;s Starlink, Microsoft Reveals</a>
Guidance: BlackBerry expects fourth-quarter revenue of $126 million to $135 million versus estimates of $161.49 million. The company anticipates fourth-quarter IoT revenue of $60 million to $65 million, secure communications revenue of $62 million to $66 million and licensing and other revenue of approximately $4 million.
BlackBerry expects full-year revenue of $517 million to $526 million versus estimates of $603.12 million. The company anticipates full-year adjusted earnings to be somewhere between breakeven and a loss of two cents per share, versus estimates for a loss of two cents per share.
Management will further discuss the quarter on a call with investors and analysts at 5:30 p.m. ET.
BB Price Action:&nbsp;<a href="https://www.benzinga.com/quote/BB" target="_blank" rel="noreferrer noopener">BlackBerry shares</a>&nbsp;were up 0.17% in after hours, trading at $2.98 at the time of publication Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Courtesy of BlackBerry.

Earnings

BlackBerry Beats Q3 Earnings Estimates, But Soft Guidance Keeps Shares In Check

Legal

SVCO

Silvaco Says US Court Of Appeals For The Ninth Circuit Affirmed US District Court's Dismissal Of All Claims Brought By Aldini

ALLETE Says FERC Approved Proposed Transaction With CPP Investments And Global Infrastructure Partners

Guidance

PARR

Par Pacific Expects 2025 Capital Expenditure And Turnaround Outlay Guidance Of $210M - $240M

11:20 EDT QNTM Stock trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>...

QNTM Stock trading resumes

11:10 EDT QNTM Stock trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking...

QNTM Stock trading halted, volatility trading pause

Quantum BioPharma announces through its subsidiary, HUGE Biopharma Australia, that sentinel dosing has started for its trial entitled "A Phase 1, R...

Quantum Group announces start of sentinel dosing in Lucid-21-302 MAD trial

Quantum Biopharma has retained the services of Agoracom, Independent Trading Group, Buyins and Stockjock.com who which will each play a key role in...

Quantum retains services of Agoracom, ITG, Buyins and Stockjock

Quantum Biopharma (TSE:QNTM) has released an update. Quantum Biopharma, formerly known as FSD Pharma Inc., has reported a notable increase in total...

Quantum Biopharma's Financial Growth and Stability

Quantum BioPharma followed up on recent events concerning the complaint filed by the Company in the United States courts, that alleges that CIBC Wo...

Quantum BioPharma invites shareholders to join market manipulation suit

Quantum Biopharma (TSE:QNTM) has released an update. Quantum Biopharma, formerly FSD Pharma, has filed a US$700 million lawsuit against major finan...

Quantum Biopharma Sues Banks for Stock Manipulation

Quantum Biopharma (TSE:QNTM) has released an update. Quantum BioPharma Ltd. announces a non-brokered private placement of convertible debenture uni...

Quantum BioPharma Launches $5 Million Private Placement

Quantum Biopharma (TSE:QNTM) has released an update. Quantum BioPharma's safety review committee has recommended moving forward with dosing the sec...

Quantum BioPharma Advances Lucid-21-302 Clinical Trial

Quantum Biopharma (TSE:QNTM) has released an update. Quantum BioPharma has successfully closed its first tranche of an offering, raising $500,000 t...

Quantum BioPharma Secures Initial Funding Tranche

Press Releases

Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Quantum BioPharma Ltd. Alleges Market Manipulation, Files Lawsuit, unbuzzed Continues To Gain Traction

Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma

Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation

Offerings

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

Comments

Quantum BioPharma

Quantum BioPharma (QNTM) Opciones

Quantum BioPharma (NASDAQ:QNTM) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL